Article

Discovery and evaluation of novel biomarkers reveal dasatinib as a potential treatment for a specific subtype of Triple-Negative Breast Cancer

2024-07-24

Abstract excerpt

Triple-negative breast cancer (TNBC) represents the most heterogeneous and aggressive subtype of breast carcinomas, characterized by the absence of clinical biomarkers (ERα, PR, and HER2) and the lack of targeted therapies. In this regard, several clinical trials have consistently failed to effectively stratify patients and identify specific treatments that elicit substantial responses. This study aims to pinpoint...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e9252c8c-df4a-5754-ba29-e7a370003312
DOI: 10.1101/2024.07.24.603752

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Discovery and evaluation of novel biomarkers reveal dasatinib as a potential treatment for a specific subtype of Triple-Negative Breast CancerDOI 10.1101/2024.07.24.603752Read

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.Semantic proximity Read

Machine learning analysis identifies genes differentiating triple negative breast cancersSemantic proximity Read

A Retrospective View on Triple Negative Breast Cancer Microenvironment: Novel Markers, Interactions, and Mechanisms of Tumor-Associated Components using public Single-cell RNA Seq DatasetsSemantic proximity Read

Secondary Transcriptomic Analysis of Triple Negative Breast Cancer Reveals Reliable Universal and Subtype-Specific BiomarkersSemantic proximity Read

Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast CancerSemantic proximity Read

Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.Semantic proximity Read

Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine LearningSemantic proximity Read

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.Semantic proximity Read

Definition of PKC-α, CDK6, and MET as Therapeutic Targets in Triple-Negative Breast CancerSemantic proximity Read

How basal are triple-negative breast cancers?Semantic proximity Read

Identification of a Gene Panel Predictive of Triple-Negative Breast Cancer Response to Neoadjuvant Chemotherapy Employing Transcriptomic and Functional ValidationSemantic proximity Read

Biomarkers for Basal-like Breast CancerSemantic proximity Read